本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ovid Therapeutics Inc.

0.7000
+0.03114.65%
盤後0.72000.0200+2.86%19:59 EDT
成交量:196.07萬
成交額:137.28萬
市值:4,977.67萬
市盈率:-2.04
高:0.7344
開:0.6800
低:0.6800
收:0.6689
資料載入中...
2020/07/13

重要事件披露

8-K - Current report
2020/06/19

重要事件披露

8-K - Current report
2020/06/17

重要事件披露

8-K - Current report
2020/06/05

重要事件披露

8-K - Current report
2020/05/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/13

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/05/07

重要事件披露

Current report, items 2.02, 8.01, and 9.01
2020/03/30

重要事件披露

Current report, items 8.01 and 9.01
2020/03/27

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/03/13

重要事件披露

Current report, items 7.01 and 9.01
2020/03/11

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/03/11

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/11

重要事件披露

Current report, items 2.02 and 9.01
2020/03/02

重要事件披露

Current report, items 7.01 and 9.01
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals